Effects of Myofascial Release Versus Dry Cupping on Pain, Muscle Length, and Functional Disabilit… (NCT07731763) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effects of Myofascial Release Versus Dry Cupping on Pain, Muscle Length, and Functional Disability in IT Professionals With Trapezitis.
Pakistan52 participantsStarted 2026-07-29
Plain-language summary
This study aims to evaluate the effectiveness of two physiotherapy techniques-Myofascial Release and Dry Cupping-in improving pain, muscle length, and functional disability in IT professionals with trapezitis. Trapezitis is a common musculoskeletal condition caused by prolonged static postures and repetitive strain, leading to neck and shoulder pain, reduced muscle flexibility, and functional limitations that affect daily activities and work performance. Although both myofascial release and dry cupping are commonly used in clinical practice, limited evidence exists comparing their effectiveness in this population. Participants diagnosed with trapezitis will be randomized into two groups: Group 1 will receive myofascial release along with routine physical therapy, and Group 2 will receive dry cupping therapy along with routine physical therapy. The interventions will be administered multiple times per week over a specified duration, and participants will be assessed before and after treatment. Outcome measures will include pain intensity using the Numeric Pain Rating Scale (NPRS), muscle length of the upper trapezius, and functional disability using the Neck Disability Index (NDI). The study will compare the effects of both interventions, focusing on pain reduction, improvement in muscle flexibility, and enhancement of functional ability. The findings may help in identifying the more effective treatment approach and contribute to improved management strategies for trapezitis among IT professionals.
Who can participate
Age range
25 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
IT professionals aged 20-65 years diagnosed with trapezitis (upper trapezius myofascial pain) characterized by pain and tenderness in the upper trapezius region for at least 4 weeks. Participants must have a pain intensity of ≥3 on the Numeric Pain Rating Scale (NPRS), exhibit restricted cervical range of motion or reduced upper trapezius muscle length as assessed using a goniometer. Functional disability must be present as indicated by a Neck Disability Index (NDI) score within the mild to moderate range (e.g., 10-28%), and be engaged in computer-based work for a minimum of 6 hours per day. Both male and female participants who provide informed consent will be included.
Exclusion Criteria:
Individuals with a history of cervical spine pathology including disc herniation, radiculopathy, or spondylosis with neurological involvement; previous trauma or surgery involving the cervical spine, shoulder girdle, or upper thoracic region; presence of symptomatic or inflammatory musculoskeletal conditions (e.g., rheumatoid arthritis, ankylosing spondylitis, fibromyalgia); neurological disorders affecting the upper limb or cervical region (e.g., peripheral neuropathy, myelopathy); skin conditions or contraindications to cupping therapy (e.g., open wounds, active infections, eczema, psoriasis); bleeding disorders or current anticoagulant therapy; pregnancy; and inability to comply with the treatment protocol or follow-up assessments will be excluded.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Numeric Pain Rating scale
Timeframe: 4 weeks
Trial details
NCT IDNCT07731763
SponsorLahore University of Biological and Applied Sciences